ADAM22 and in situ carcinoma: Disintegrin and metalloproteinase domain-containing protein ADAM22, a molecule that bridges the postsynaptic membrane and is known to play a key role in synapse maturation, synapsis transmission, and myelination91, was also decreased in MS/CIS patients compared to controls.